Literature DB >> 23412426

Blood pressure for optimal health-related quality of life in hypertensive patients.

Monika Zygmuntowicz1, Aleksander Owczarek, Adam Elibol, Magdalena Olszanecka-Glinianowicz, Jerzy Chudek.   

Abstract

OBJECTIVE: The optimal blood pressure (BP) in terms of health-related quality of life (HRQoL) in patients treated for hypertension remains unknown. This study aimed to determine BP values associated with optimal HRQoL among younger (<65 years old) and older patients (≥65 years old) treated for hypertension.
METHODS: HRQoL was assessed using the 12-Item Short Form Health Survey in 11,498 unselected white patients treated for hypertension for at least 12 months.
RESULTS: BP values associated with highest Physical Component Summary (PCS) were similar for older patients and those less than 65 years old (125/80 and 125/75 mmHg, respectively). BP values associated with the highest Mental Component Summary (MCS) scores were slightly higher for older patients (123/80 and 115/75 mmHg, respectively). The scores varied depending on the number of antihypertensive drugs. Compared with patients prescribed monotherapy, SBP associated with the highest PSC scores was increased by 11 mmHg in patients taking two or three drugs, and by 15 mmHg in patients taking at least four drugs. However, DBP values associated with the highest PCS scores and BP values associated with the highest MCS scores showed little difference according to drug regimens. Results of multivariate regression analysis adjusted for BP control revealed that PCS score was more strongly associated with age, presence of multiple comorbidities and duration of antihypertensive therapy, whereas MCS score was more strongly associated with multiple comorbidities and number of antihypertensive drugs.
CONCLUSION: BP values associated with optimal HRQoL are similar in younger and older patients treated for hypertension and are within the recommended goals. However, BP values associated with optimal HRQoL increase with the number of antihypertensive drugs, reflecting severity of the disease. Therefore, therapeutic goals should be individualized to prevent HRQoL deterioration.

Entities:  

Mesh:

Year:  2013        PMID: 23412426     DOI: 10.1097/HJH.0b013e32835ebdd7

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  8 in total

Review 1.  Resistant Hypertension: Mechanisms and Treatment.

Authors:  Andrew Y Hwang; Eric Dietrich; Carl J Pepine; Steven M Smith
Journal:  Curr Hypertens Rep       Date:  2017-07       Impact factor: 5.369

2.  Physician-pharmacist collaboration versus usual care for treatment-resistant hypertension.

Authors:  Steven M Smith; Nicholas W Carris; Eric Dietrich; John G Gums; Liz Uribe; Christopher S Coffey; Tyler H Gums; Barry L Carter
Journal:  J Am Soc Hypertens       Date:  2016-01-18

3.  Systolic Blood Pressure and Cognitive Decline in Older Adults With Hypertension.

Authors:  Sven Streit; Rosalinde K E Poortvliet; Wendy P J den Elzen; Jeanet W Blom; Jacobijn Gussekloo
Journal:  Ann Fam Med       Date:  2019-03       Impact factor: 5.166

Review 4.  Quality of Life in Treatment-Resistant Hypertension.

Authors:  Nicholas W Carris; Steven M Smith
Journal:  Curr Hypertens Rep       Date:  2015-08       Impact factor: 5.369

5.  Resistant Hypertension and Susceptible Outcomes: Exploring the Benefits of Aggressive Blood Pressure Control.

Authors:  Steven M Smith
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-10-05       Impact factor: 3.738

6.  The relationship between sleep disturbances and quality of life in elderly patients with hypertension.

Authors:  Izabella Uchmanowicz; Karolina Markiewicz; Bartosz Uchmanowicz; Aleksandra Kołtuniuk; Joanna Rosińczuk
Journal:  Clin Interv Aging       Date:  2019-01-15       Impact factor: 4.458

7.  Cross-cultural adaptation of the Spanish MINICHAL instrument into English for use in the United Kingdom.

Authors:  Andrew N Jordan; Christine Anning; Lindsay Wilkes; Claire Ball; Nicola Pamphilon; Christopher E Clark; Nicholas G Bellenger; Angela C Shore; Andrew S P Sharp; Jose M Valderas
Journal:  Health Qual Life Outcomes       Date:  2022-03-04       Impact factor: 3.186

8.  Optimal Systolic Blood Pressure Target in Resistant and Non-Resistant Hypertension: A Pooled Analysis of Patient-Level Data from SPRINT and ACCORD.

Authors:  Steven M Smith; Matthew J Gurka; David A Calhoun; Yan Gong; Carl J Pepine; Rhonda M Cooper-DeHoff
Journal:  Am J Med       Date:  2018-08-22       Impact factor: 4.965

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.